The U.S. Food and Drug Administration (FDA) recently released its long-awaited draft guidance supporting the use of decentralized clinical trials (DCTs) for drugs, biologics, and devices. The new guidance clarifies the FDA's position on DCTs, inspiring confidence in their use...
